SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing presentation: reset
STANDARD VS DOUBLE DOSE DOLUTEGRAVIR IN HIV-ASSOCIATED TUBERCULOSIS: WEEK 48 RESULTS
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
1 of
1
|
STANDARD VS DOUBLE DOSE DOLUTEGRAVIR IN HIV-ASSOCIATED TUBERCULOSIS: WEEK 48 RESULTS (ABSTRACT
110)
Rulan Griesel
University of Cape Town, Cape Town, South Africa
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
1 of
1
|
